These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
398 related items for PubMed ID: 17067460
41. Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression. Imaizumi R, Akasaka Y, Inomata N, Okada E, Ito K, Ishikawa Y, Maruyama Y. Histopathology; 2009 May; 54(6):722-30. PubMed ID: 19438747 [Abstract] [Full Text] [Related]
43. Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus. Hadzi-Mihailovic M, Raybaud H, Monteil R, Cakic S, Djuric M, Jankovic L. J BUON; 2010 Oct; 15(2):362-8. PubMed ID: 20658736 [Abstract] [Full Text] [Related]
44. Caveolin-1 expression in oral lichen planus, dysplastic lesions and squamous cell carcinoma. Jaafari-Ashkavandi Z, Aslani E. Pathol Res Pract; 2017 Jul; 213(7):809-814. PubMed ID: 28554768 [Abstract] [Full Text] [Related]
45. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma. Kawata N, Nagane Y, Hirakata H, Ichinose T, Okada Y, Yamaguchi K, Takahashi S. Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184 [Abstract] [Full Text] [Related]
46. Assessment of local angiogenesis and vascular endothelial growth factor in the patients with atrophic-erosive and reticular oral lichen planus. Tao X, Huang Y, Li R, Qing R, Ma L, Rhodus NL, Cheng B. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 May; 103(5):661-9. PubMed ID: 17306572 [Abstract] [Full Text] [Related]
47. Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2. Brun JL, Cortez A, Commo F, Uzan S, Rouzier R, Daraï E. Int J Oncol; 2008 Dec; 33(6):1239-46. PubMed ID: 19020757 [Abstract] [Full Text] [Related]
48. A role for the substance P/NK-1 receptor complex in cell proliferation and apoptosis in oral lichen planus. González Moles MA, Esteban F, Ruiz-Avila I, Gil Montoya JA, Brener S, Bascones-Martínez A, Muñoz M. Oral Dis; 2009 Mar; 15(2):162-9. PubMed ID: 19036058 [Abstract] [Full Text] [Related]
49. The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Rhodus NL, Cheng B, Myers S, Miller L, Ho V, Ondrey F. Mol Carcinog; 2005 Oct; 44(2):77-82. PubMed ID: 16075467 [Abstract] [Full Text] [Related]
50. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2. Nishida Y, Miyamori H, Thompson EW, Takino T, Endo Y, Sato H. Cancer Res; 2008 Nov 01; 68(21):9096-104. PubMed ID: 18974156 [Abstract] [Full Text] [Related]
51. A clinical study of 674 patients with oral lichen planus in China. Xue JL, Fan MW, Wang SZ, Chen XM, Li Y, Wang L. J Oral Pathol Med; 2005 Sep 01; 34(8):467-72. PubMed ID: 16091113 [Abstract] [Full Text] [Related]
52. Update of the cancer-associated molecular mechanisms in oral lichen planus, a disease with possible premalignant nature. Georgakopoulou EA, Troupis TG, Troupis G, Gorgoulis VG. J BUON; 2011 Sep 01; 16(4):613-6. PubMed ID: 22331711 [Abstract] [Full Text] [Related]
53. Decreased expression of p63 in oral lichen planus and graft-vs.-host disease associated with oral inflammation. Ebrahimi M, Wahlin YB, Coates PJ, Sjöström B, Nylander K. J Oral Pathol Med; 2006 Jan 01; 35(1):46-50. PubMed ID: 16393253 [Abstract] [Full Text] [Related]
54. Upregulation of transient receptor potential vanilloid type-1 receptor expression in oral lichen planus. Bán A, Marincsák R, Bíró T, Perkecz A, Gömöri E, Sándor K, Tóth IB, Bánvölgyi A, Szolcsányi J, Pintér E. Neuroimmunomodulation; 2010 Jan 01; 17(2):103-8. PubMed ID: 19923855 [Abstract] [Full Text] [Related]
55. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats. Hu YB, Li DG, Lu HM. J Gene Med; 2007 Mar 01; 9(3):217-29. PubMed ID: 17351970 [Abstract] [Full Text] [Related]
56. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. van der Meij EH, Mast H, van der Waal I. Oral Oncol; 2007 Sep 01; 43(8):742-8. PubMed ID: 17112770 [Abstract] [Full Text] [Related]
57. May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer? Shrestha B, Bajracharya D, Byatnal AA, Kamath A, Radhakrishnan R. Pathol Oncol Res; 2017 Jan 01; 23(1):197-206. PubMed ID: 27853937 [Abstract] [Full Text] [Related]
58. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps. Chen YS, Langhammer T, Westhofen M, Lorenzen J. Allergy; 2007 Jan 01; 62(1):66-72. PubMed ID: 17156344 [Abstract] [Full Text] [Related]
59. Evaluation of MYC status in oral lichen planus in patients with progression to oral squamous cell carcinoma. Segura S, Rozas-Muñoz E, Toll A, Martín-Ezquerra G, Masferrer E, Espinet B, Rodriguez M, Baró T, Barranco C, Pujol RM. Br J Dermatol; 2013 Jul 01; 169(1):106-14. PubMed ID: 23461699 [Abstract] [Full Text] [Related]
60. Role of matrix metalloproteinases and their tissue inhibitor of metalloproteinases in myxomatous change of cardiac floppy valves. Togashi M, Tamura K, Nitta T, Ishizaki M, Sugisaki Y, Fukuda Y. Pathol Int; 2007 May 01; 57(5):251-9. PubMed ID: 17493172 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]